C
TransMedics Group, Inc. TMDX
$125.17 -$3.33-2.59% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025
Revenue 9.64% 18.02%
Total Other Revenue -- --
Total Revenue 9.64% 18.02%
Cost of Revenue 9.89% 11.49%
Gross Profit 9.48% 22.52%
SG&A Expenses 1.06% -6.99%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 4.06% 2.76%
Operating Income 33.25% 217.48%
Income Before Tax 35.64% 281.69%
Income Tax Expenses 28.27% 653.03%
Earnings from Continuing Operations 35.92% 274.54%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 35.92% 274.54%
EBIT 33.25% 217.48%
EBITDA 28.94% 134.43%
EPS Basic 35.15% 273.15%
Normalized Basic EPS 34.87% 280.31%
EPS Diluted 30.83% 251.10%
Normalized Diluted EPS 33.49% 236.58%
Average Basic Shares Outstanding 0.57% 0.38%
Average Diluted Shares Outstanding 1.61% 13.36%
Dividend Per Share -- --
Payout Ratio -- --